SMS Pharmaceuticals has informed that the company has received disclosure from the designated employee, Krishna Chaitanya Potluri in pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 on 17th December, 2020. Further details of the same as enclosed.
The above information is a part of company’s filings submitted to BSE.